ArticleInternational journal of experimental pathology2017

Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer.

Apiwat Pugongchai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.